HARVARD BIOSCIENCE, INC. Total Liabilities
HARVARD BIOSCIENCE, INC. (HBIO) had Total Liabilities of $68.87 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-11
- 2026-06-30: Liabilities $68.87M.
- 2026-03-31: Liabilities $67.89M.
- 2025-12-31: Liabilities $66.34M.
- 2025-09-30: Liabilities $63.92M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $68.87M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $67.89M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $66.34M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $63.92M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $64.36M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $64.97M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $63.30M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $65.92M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $61.66M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $64.35M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $64.29M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $65.45M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $67.51M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $71.24M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $73.14M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $75.03M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $77.77M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $81.67M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $78.94M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $76.98M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $75.27M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $74.13M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $79.57M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $72.45M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $74.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $80.25M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $83.18M 10-K/A · filed 2021-03-17 | |
| 2019-09-30 | $85.67M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $85.91M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $90.99M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $85.89M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $84.08M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $88.04M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $91.65M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $28.45M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $33.77M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $33.65M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $34.68M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $35.57M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $36.28M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $37.42M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $39.69M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $42.45M 10-K · filed 2017-03-17 | $42.62M 10-K · filed 2016-04-29 |
| 2015-09-30 | $39.27M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $43.76M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $43.62M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $40.45M 10-K · filed 2016-04-29 | |
| 2014-09-30 | $39.35M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $39.48M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $39.11M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $40.98M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $40.50M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $40.67M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $31.05M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $29.27M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $30.22M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $31.52M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $33.40M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $31.14M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $30.99M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $32.20M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $34.55M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |